|
|
Volumn 34, Issue 12, 2004, Pages 980-984
|
|
Oral and intravenous caffeine for treatment of children with post-sedation paradoxical hyperactivity
|
|
Author keywords
Adverse event; Caffeine; Hyperactivity; Sedation
|
|
Indexed keywords
CAFFEINE;
CAFFEINE CITRATE;
CHLORAL HYDRATE;
FENTANYL;
MIDAZOLAM;
MORPHINE SULFATE;
MOUNTAIN DEW;
PENTOBARBITAL;
AGITATION;
ARTICLE;
CHILD;
CHILD BEHAVIOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRYING;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
HYPERACTIVITY;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RADIOLOGICAL PROCEDURES;
SEDATION;
SYMPTOMATOLOGY;
ADMINISTRATION, ORAL;
ADOLESCENT;
ANESTHETICS, INTRAVENOUS;
CAFFEINE;
CASE-CONTROL STUDIES;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
FENTANYL;
HUMANS;
HYPNOTICS AND SEDATIVES;
INFANT;
INJECTIONS, INTRAVENOUS;
MALE;
MIDAZOLAM;
PENTOBARBITAL;
PSYCHOMOTOR AGITATION;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 9444281483
PISSN: 03010449
EISSN: None
Source Type: Journal
DOI: 10.1007/s00247-004-1303-8 Document Type: Article |
|
Times cited : (24)
|
|
References (8)
|
